At DENALI THERAPEUTICS, I am dedicated to develop breakthrough therapies for neurodegenerative diseases (Alzheimer’s, Parkinson’s, ALS, others).
I am using insight from human genetics to reveal new targets and pathways, and the latest molecular, cellular, and imaging techniques to investigate the underlying biology of neurodegeneration. I work closely with medicinal chemists, biologists, and pathway leaders to identify relevant biomarkers and biological pathways that will improve our understanding, diagnosis, and treatment of neurodegenerative diseases.
Company: Denali Therapeutics
Location: South San Francisco